Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Ezetimibe/Simvastatin vs Atorvastatin in Hypercholesterolemia
NCT00092690Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jun 2003
- Primary completion
- Mar 2004
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
Phase 3, randomised, double-blind trial of Vytorin in hypercholesterolemia (2 arms), sponsored by Organon & Co. Primary endpoint: Plasma Low-Density Lipoprotein Cholesterol at 6 weeks. Started Jun 2003; status: completed.
02
Drugs
Vytorin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00092690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092690.